Meeting the American Diabetes Association Standards of Care: An Algorithmic Approach to Clinical Care of the Diabetes Patient / Edition 1by Mayer B. Davidson
Pub. Date: 02/05/2010
Publisher: American Diabetes Association
Improving glycemic, lipid, and blood pressure outcomes is the essence of diabetes care. Maintaining consistently positive results is an ongoing challenge for every healthcare professional. After years of clinical practice, Mayer Davidson, MD, has developed a series of algorithmic techniques that can increase positive results. Based on ADA's Standards of Care, this
Improving glycemic, lipid, and blood pressure outcomes is the essence of diabetes care. Maintaining consistently positive results is an ongoing challenge for every healthcare professional. After years of clinical practice, Mayer Davidson, MD, has developed a series of algorithmic techniques that can increase positive results. Based on ADA's Standards of Care, this book offers detailed treatment algorithms that have been shown to be clinically effective in improving outcomes in people with diabetes.
- American Diabetes Association
- Publication date:
- Product dimensions:
- 6.10(w) x 9.10(h) x 0.50(d)
Table of Contents
Chapter 1. Laying the Groundwork (General Background, Glycemia, Lipids, Renal Evaluation, Hypertension, Aspirin, Smoking Cessation, Rationale for Algorithms); Chapter 2. Evidence-Based Principles of Dietary Therapy; Chapter 3. Glycemia (Goals of Therapy, Principles of Treatment, Non-Insulin Drugs, Metformin, Sulfonylurea Agents and Glinides, Thiazolidinediones; Incretins – Background, Incretin Analogs (Exenatide), Dipeptidyl Peptidase Inhibitors (Sitagliptin), Alpha-Glucosidase Inhibitors, Markedly Symptomatic Type 2 Diabetic Patients. Pramlintide, Self Monitoring of Blood Glucose, Insulin, General Approach, Bedtime Insulin / Daytime Oral Antidiabetes Drugs, Multiple Injections, Premixed Insulins, Delayed Response to NPH Insulin, Correction Doses, Glycemia Algorithm)Chapter 4. Dyslipidemia (Goals of Therapy, Principles of Treatment, Adverse Events, Medications, Dyslipidemia Algorithm); Chapter 5. Hypertension, Background (Aldosterone Receptor Antagonists, Alpha-Adrenergic Receptor Atagonists, Alpha-Adrenergic Receptor Agonists, Angiotensin Converting Enzyme Inhibitors, Angiotensin II Receptor Antagonists, Beta-Adrenergic Receptor, Antagonists, Calcium Channel Antagonists, Renin Inhibitors, Thiazide and Loop Diuretics, Vasodilators (Direct), Hypertension Algorithm)
About the Author
Mayer Davidson, MD is a well-known and respected researcher and an expert in clinical endocrinology. He is a Professor of Medicine at the UCLA School of Medicine and a Principal Investigator at the Clinical Center for Research Excellence at the Charles Drew University of Medicine and Science (Los Angeles). He is very active in the ADA community and was Editor-in-Chief of Diabetes Care from 2002 to 2006 and President of the American Diabetes Association from 1997 to 1998.
and post it to your social network
Most Helpful Customer Reviews
See all customer reviews >